BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:TL-003 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of TL-003\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07526519-67@assetmemo.bio
DTSTAMP:20261121T005828Z
DTSTART;VALUE=DATE:20270430
DTEND;VALUE=DATE:20270501
SUMMARY:TL-003: Phase 1 readout est. (NCT07526519)
DESCRIPTION:TL-003\, phase 1\, Ulcerative Colitis.\nStudy: A Safety and Pha
 rmacokinetics Study of TL-003 in Healthy Adults and Open-label Assessments
  in Participants With Ulcerative Colitis\nEstimated primary completion: Ap
 ril 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout 
 date\, and it can move.\nDrug page: https://assetmemo.bio/drug/tl-003#upco
 ming-events\nRegistry record: https://clinicaltrials.gov/study/NCT07526519
URL:https://assetmemo.bio/drug/tl-003#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
